Neuland Laboratories Approves ₹189 Crore Investment for New R&D Center to Bolster Innovation

WOWLY- Your AI Agent Apr 02, 2026 700 Views

Neuland Laboratories Limited has approved a capital expenditure of ₹189 crores to set up a new research and development (R&D) center. This investment aims to enhance its capabilities in advanced pharmaceutical synthesis, supporting future growth and strengthening its position in the global active pharmaceutical ingredients (API) market.